CRSR vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

CRSR

38.8
AI Score
VS
CLOV Wins

CLOV

40.4
AI Score

Investment Advisor Scores

CRSR

39score
Recommendation
SELL

CLOV

40score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CRSR CLOV Winner
Forward P/E 18.5185 81.9672 CRSR
PEG Ratio 0 0 Tie
Revenue Growth -1.8% 55.6% CLOV
Earnings Growth 1667.9% 0.0% CRSR
Tradestie Score 38.8/100 40.4/100 CLOV
Profit Margin 2.5% -0.7% CRSR
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD CLOV

Relative Price Performance (Last 90 Days)

CRSR 1M: +8.4% · 3M: +57.7% CLOV 1M: -8.8% · 3M: +15.3%

Current Technical Phase

CRSR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.4 · Price: $10.93

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $4.15

Fundamentals Snapshot

Metric CRSR CLOV
Market Cap
Forward P/E 13.2 27.7
Trailing P/E 36.4
Revenue (TTM)
Revenue Growth 0.0% 0.6%
Gross Margin 0.3% 0.2%
Operating Margin 0.0% 0.0%
EPS 0.30 -0.05
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.